Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Toronto
$70,000.00
Role of C-Type Natriuretic Peptide in Aortic Valve Disease
FY 2010-11
Summary
Calcific aortic valve disease (CAVD) is one of the most common cardiovascular diseases, and little is known about the mechanisms which cause and worsen it. Current treatments require surgical replacement of the heart valve (which suffers from serious side effects), and at present there are no effective drug treatments.
Previous work in our laboratory has used cell culture techniques to identify a small protein (C-type Natriuretic Peptide, or CNP) which protects valve cells from becoming fibrotic or calcified. The primary objectives of this study are to a) better characterize the development of CAVD in a disease model relevant to human health, and b) determine the functional role of CNP in this relevant model.
In this study, normal mice and mutant mice lacking functional CNP will be fed a high-fat/high-carbohydrate diet for up to four months in order to induce CAVD. The heart and aortic valves of these mutant mice have never before been studied. After four months of the high-fat/high-carbohydrate diet, we will then examine their aortic valves with a number of techniques such as high-resolution ultrasound and laser imaging. We will also look for changes in the expression of several genes which have previously been suspected to cause valve disease, and also genes which we believe are responsible for the protective effect of CNP. It is expected that mice without functional CNP will develop much more serious and accelerated valve disease when compared to normal mice.
This work will greatly improve personal health by confirming a functional role for CNP in protecting against CAVD, thereby making this protein a candidate for future therapeutic use in humans. This work will also greatly contribute to the research community's knowledge about the causes and progression of aortic valve disease. Lastly, identification of the genes which are responsible for CNP's protective effect will identify other drug targets which may also prevent the onset of this deadly disease.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
229515
Name
Blaser Mark C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Role of C-Type Natriuretic Peptide in Aortic Valve Disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$70,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Aortic Valve Disease; C-Type Natriuretic Peptide; Cell Signalling; Mechanobiology; Mouse Models Of Disease; Myofibroblast; Real-Time Pcr; Ultrasound Biomicroscopy; Valve Interstitial Cell; Western Blotting
Abstract
Calcific aortic valve disease (CAVD) is one of the most common cardiovascular diseases, and little is known about the mechanisms which cause and worsen it. Current treatments require surgical replacement of the heart valve (which suffers from serious side effects), and at present there are no effective drug treatments.
Previous work in our laboratory has used cell culture techniques to identify a small protein (C-type Natriuretic Peptide, or CNP) which protects valve cells from becoming fibrotic or calcified. The primary objectives of this study are to a) better characterize the development of CAVD in a disease model relevant to human health, and b) determine the functional role of CNP in this relevant model.
In this study, normal mice and mutant mice lacking functional CNP will be fed a high-fat/high-carbohydrate diet for up to four months in order to induce CAVD. The heart and aortic valves of these mutant mice have never before been studied. After four months of the high-fat/high-carbohydrate diet, we will then examine their aortic valves with a number of techniques such as high-resolution ultrasound and laser imaging. We will also look for changes in the expression of several genes which have previously been suspected to cause valve disease, and also genes which we believe are responsible for the protective effect of CNP. It is expected that mice without functional CNP will develop much more serious and accelerated valve disease when compared to normal mice.
This work will greatly improve personal health by confirming a functional role for CNP in protecting against CAVD, thereby making this protein a candidate for future therapeutic use in humans. This work will also greatly contribute to the research community's knowledge about the causes and progression of aortic valve disease. Lastly, identification of the genes which are responsible for CNP's protective effect will identify other drug targets which may also prevent the onset of this deadly disease.
Competitiondate
201010
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Blaser, Mark C
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $70,000~ $0~